Published in Exp Diabetes Res on June 20, 2011
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes. ISRN Endocrinol (2012) 0.78
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes. PLoS One (2012) 0.78
Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes. Cell Stem Cell (2017) 0.75
The physiology of glucagon-like peptide 1. Physiol Rev (2007) 9.07
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A (2007) 4.62
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem (1993) 3.23
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem (1992) 2.81
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest (1968) 2.46
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem (1986) 2.22
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol (1993) 2.12
Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology (1999) 2.04
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm (2005) 1.96
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology (1986) 1.80
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol (1997) 1.67
Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem (2001) 1.45
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes (2007) 1.36
Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther (1998) 1.35
Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism (1966) 1.35
Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes (1993) 1.30
The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes (2003) 1.30
Minireview: update on incretin biology: focus on glucagon-like peptide-1. Endocrinology (2010) 1.29
Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol (2003) 1.23
Proglucagon processing in porcine and human pancreas. J Biol Chem (1994) 1.18
GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival. Diabetes Metab (2008) 1.15
Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J Clin Endocrinol Metab (1995) 1.12
Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes (1999) 1.08
Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J Biol Chem (1997) 1.01
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon (2010) 1.00
Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes. Mol Ther (2005) 0.99
Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology (2003) 0.99
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes. Gene Ther (2006) 0.97
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther (2008) 0.95
Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon. FEBS Lett (1997) 0.95
GLP-1 gene delivery for the treatment of type 2 diabetes. Mol Ther (2003) 0.95
Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Endocrinology (1989) 0.94
Salivary epithelial cells: an unassuming target site for gene therapeutics. Int J Biochem Cell Biol (2010) 0.93
Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Ther (2006) 0.92
In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes. Gene Ther (2007) 0.90
Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland. Endocrinology (2010) 0.90
Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem (1987) 0.89
Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology (2003) 0.89
DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes. Gene Ther (2009) 0.88
In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes. Diabetes (2010) 0.88
Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716. Regul Pept (2010) 0.88
α-Galactosidase A expressed in the salivary glands partially corrects organ biochemical deficits in the fabry mouse through endocrine trafficking. Hum Gene Ther (2011) 0.88
Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice. J Endocrinol (2001) 0.87
Altered proglucagon processing in an alpha-cell line derived from prohormone convertase 2 null mouse islets. J Biol Chem (2004) 0.87
Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer. Hum Gene Ther (2011) 0.86
Salivary gland gene therapy. Dent Clin North Am (2006) 0.84
Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats. J Gene Med (2008) 0.82
Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1. Mol Ther (2007) 0.82
A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis. Biochem Biophys Res Commun (2010) 0.82
Gene therapy of salivary diseases. Methods Mol Biol (2010) 0.80
Amelioration of hyperglycemia by intestinal overexpression of glucagon-like peptide-1 in mice. J Mol Med (Berl) (2009) 0.79
Treatment of diabetes with glucagon-like peptide-1 gene therapy. Expert Opin Biol Ther (2010) 0.78
Immunocytochemical finding of the amidating enzymes in mouse pancreatic A-, B-, and D-cells: a comparison with human and rat. J Histochem Cytochem (2002) 0.76
Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med (2003) 2.43
The family Parvoviridae. Arch Virol (2013) 2.12
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J Virol (2006) 1.97
Timolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery. Eur J Ophthalmol (2014) 1.97
Btbd7 regulates epithelial cell dynamics and branching morphogenesis. Science (2010) 1.75
Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum (2009) 1.67
Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci U S A (2004) 1.64
Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60
AAV transcytosis through barrier epithelia and endothelium. Mol Ther (2005) 1.60
Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther (2002) 1.60
Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci (2005) 1.56
The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med (2009) 1.55
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther (2010) 1.51
Structure of adeno-associated virus serotype 5. J Virol (2004) 1.50
Structure of adeno-associated virus type 4. J Virol (2005) 1.47
Cloning and characterization of a bovine adeno-associated virus. J Virol (2004) 1.46
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J Virol (2003) 1.37
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome. Hum Gene Ther (2003) 1.28
Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J Biol Chem (2002) 1.27
Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol (2005) 1.23
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat Med (2010) 1.22
Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol (2009) 1.20
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther (2006) 1.17
Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 1.17
The parvovirus capsid odyssey: from the cell surface to the nucleus. Trends Microbiol (2008) 1.15
Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol (2009) 1.15
A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons. Mol Cell Neurosci (2008) 1.15
Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther (2010) 1.13
Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks. J Virol (2006) 1.13
Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther (2003) 1.12
Coordinated control of connexin 26 and connexin 30 at the regulatory and functional level in the inner ear. Proc Natl Acad Sci U S A (2008) 1.11
Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements. Mol Ther (2008) 1.10
Carboxypeptidase E cytoplasmic tail-driven vesicle transport is key for activity-dependent secretion of peptide hormones. Mol Endocrinol (2008) 1.10
Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther (2007) 1.10
Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med (2010) 1.09
PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J (2003) 1.08
IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer. Lab Invest (2010) 1.07
Absence of carboxypeptidase E leads to adult hippocampal neuronal degeneration and memory deficits. Hippocampus (2008) 1.05
A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol Ther (2005) 1.05
Fluorescent cargo proteins in pancreatic beta-cells: design determines secretion kinetics at exocytosis. Biophys J (2004) 1.02
Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors. J Gene Med (2005) 1.02
Carboxypeptidase E/NFα1: a new neurotrophic factor against oxidative stress-induced apoptotic cell death mediated by ERK and PI3-K/AKT pathways. PLoS One (2013) 1.02
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers. J Clin Invest (2011) 1.02
Capsid antibodies to different adeno-associated virus serotypes bind common regions. J Virol (2013) 1.01
Carboxypeptidase E is required for normal synaptic transmission from photoreceptors to the inner retina. J Neurochem (2005) 1.00
Identification of adeno-associated virus contamination in cell and virus stocks by PCR. Biotechniques (2004) 0.99
Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta (2005) 0.99
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4. Virology (2003) 0.98
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy. J Transl Med (2010) 0.96
Partial redirection of transgenic human growth hormone secretion from rat salivary glands. Hum Gene Ther (2005) 0.96
Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells. J Mol Neurosci (2004) 0.95
BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96. PLoS One (2010) 0.94
Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther (2002) 0.93
Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome. Arthritis Res Ther (2009) 0.93
Aquaporin 1 is important for maintaining secretory granule biogenesis in endocrine cells. Mol Endocrinol (2008) 0.93
Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5. J Gen Virol (2011) 0.93
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92
Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J Virol (2008) 0.92
Structural insights into adeno-associated virus serotype 5. J Virol (2013) 0.92
The transmembrane domain of the prohormone convertase PC3: a key motif for targeting to the regulated secretory pathway. Mol Cell Endocrinol (2006) 0.91
Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectors. J Gene Med (2009) 0.91
BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice. PLoS One (2011) 0.90
Re-engineering primary epithelial cells from rhesus monkey parotid glands for use in developing an artificial salivary gland. Tissue Eng (2006) 0.90
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther (2012) 0.90
Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland. Endocrinology (2010) 0.90
Sorting behavior of a transgenic erythropoietin-growth hormone fusion protein in murine salivary glands. Hum Gene Ther (2008) 0.89
Carboxypeptidase E cytoplasmic tail mediates localization of synaptic vesicles to the pre-active zone in hypothalamic pre-synaptic terminals. J Neurochem (2010) 0.87
Carboxypeptidase E (NF-α1): a new trophic factor in neuroprotection. Neurosci Bull (2014) 0.87
Carboxypeptidase E knockout mice exhibit abnormal dendritic arborization and spine morphology in central nervous system neurons. J Neurosci Res (2010) 0.86
Mechanisms of translational regulation by a human eIF5-mimic protein. Nucleic Acids Res (2011) 0.86
Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome. PLoS One (2011) 0.86
Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells. Mol Endocrinol (2011) 0.86
Viral vector tropism for supporting cells in the developing murine cochlea. Hear Res (2011) 0.85
The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes. FASEB J (2012) 0.85
Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response. Mol Ther (2011) 0.85
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68. BMC Cancer (2011) 0.85
Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS. Mol Ther (2007) 0.84
Sorting of growth hormone-erythropoietin fusion proteins in rat salivary glands. Biochem Biophys Res Commun (2008) 0.84
Sites in the AAV5 capsid tolerant to deletions and tandem duplications. Arch Biochem Biophys (2010) 0.83
Adeno-associated virus type 2 Rep78 inhibition of PKA and PRKX: fine mapping and analysis of mechanism. J Virol (2002) 0.83
Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death. J Mol Neurosci (2011) 0.82
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One (2011) 0.82
Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.81
Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul Pept (2009) 0.81
Recovery of radiation-induced dry eye and corneal damage by pretreatment with adenoviral vector-mediated transfer of erythropoietin to the salivary glands in mice. Hum Gene Ther (2013) 0.80
Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice. Arthritis Rheum (2013) 0.80
Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. Mol Ther (2013) 0.79
Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation. PLoS One (2012) 0.79
Expression and secretion of human proinsulin-B10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus. PLoS One (2013) 0.79
Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glands. Toxicol Sci (2011) 0.78